Intelomed, Inc. Named Pittsburgh Tech 50 Awards Finalist

PITTSBURGH, Aug. 25, 2014 /PRNewswire/ -- Intelomed, Inc., developer of CVInsight®, a solution to noninvasively monitor physiologic stress placed on the cardiovascular system, announced today that the Pittsburgh Technology Council has named it a Tech 50 Awards Finalist in the Innovator of the Year Category.

The Pittsburgh Technology Council's annual Tech 50 Awards recognize southwestern Pennsylvania's most successful, innovative, and thought-leading technology companies, which have become the backbone of Pittsburgh's new economy.

The awards represent transformative technology centers of excellence with tech companies at all stages of growth. Tech 50 also recognizes the region's top tech executive.

"Each year, the Council canvasses the region for the most distinguished public and private technology-oriented companies, and the Tech 50 awards honor those companies that demonstrated the strongest growth and advancement in product or sales success, financial strength, corporate citizenship, job growth and retention and innovative product or technology," said Audrey Russo, President and CEO, Pittsburgh Technology Council. "We are excited to announce the category winners at the awards gala this fall. It is truly a night to celebrate our region's technology companies and the contributions they have made to our economic vitality."

"We are very pleased to be included in this impressive group of innovators," said Frank Amoruso, President and CEO of Intelomed, Inc. "The solution that Intelomed offers, CVInsight® is something that we believe will be instrumental in raising the bar for improved patient monitoring and care."

Tech 50 winners will be announced on October 21, 2014 at the Wyndham Grand Pittsburgh.

For further information on Intelomed, Inc. and its solutions please visit www.intelomed.com.

For more information on Tech 50, visit http://tech50.pghtech.org. For more information on the Pittsburgh Technology Council, visit www.pghtech.org.

Logo - http://photos.prnewswire.com/prnh/20140227/MM74067LOGO

SOURCE Intelomed, Inc.